Monocyte-derived macrophage cytokine responses induced by M. bovis BCG

Tubercle and Lung Disease

Volumn 80, Issue 4-5, 2000, Pages 197-207

  Atkinson, S ^a   Valadas, E ^a   Smith, S M ^a   Lukey, P T ^b   Dockrell, H M ^a  

^a Immunology Unit   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; FLUORESCENT DYE; MONOKINE;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSIVE ELEMENT; FEMALE; FLOW CYTOMETRY; HUMAN; INFECTION RATE; INFLAMMATION; MACROPHAGE FUNCTION; MALE; MYCOBACTERIUM BOVIS; NORMAL HUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033749577     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1054/tuld.2000.0247     Document Type: Article

References (43)

1. Tuberculosis: Commentary on a re-emergent killer
2. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic
3. Efficiency of BCG vaccine against leprosy and tuberculosis in northern Malawi
4. Mycobacterium tuberculosis and the complement system
5. Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages
6. Induction of IFN-γ,-producing CD4+ natural killer T cells by Mycobacterium bovis bacillus Calmette Guerin
7. Characterisation of human Mycobacterium bovis BCG-reactive CD8 + T cells
8. Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8 + T cells in vitro
9. Growth inhibition of Mycobacterium bovis by IFN-γ stimulated macrophages: Regulation by endogenous tumour necrosis factor-α and by IL-10
10. Complement receptor-mediated uptake and tumour necrosis factor-α-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages
11. The inducing role of tumour necrosis factor in the development of bactericidal granulomas during BCG infection
12. Local production of tumour necrosis factor and IFN-γ in tuberculosis pleuritis
13. The role of interleukin-12 in acquired immunity to M. tuberculosis infection
14. Activation of protein kinase C by mycobacterial cord factor, trehalose 6-monomycolate, resulting in tumour necrosis factor-α release in mouse lung tissues
15. The interleukin-12 gene expression in human monocyte-derived macrophages stimulated with Mycobacterium bovis BCG: Cytokine regulation and effect on NK cells
16. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages
17. Effect of mycobacteria on sensitivity to the cytotoxic effects of tumour necrosis factor
18. Lethal tuberculosis in interleukin-6-deficient mice
19. Interleukin-10 rescues T cells from apoptotic cell death: Association with an upregulation of Bcl-2
20. Serum concentration of cytokines in patients with active tuberculosis and after treatment
21. Expression of virulence of Mycobacterium tuberculosis within human monocytes: Virulence correlates with intracellular growth and induction of tumour necrosis factor alpha but not with evasion of lumphocyte-dependent monocyte effector functions
22. Modulation of monocytic cell activity and virus susceptibility during differentiation into macrophages
23. Nonopsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese hamster ovary cells
24. Characterisation of mannose receptor-dependent phagocytosis mediated by Mycobacterium tuberculosis lipoarabinomannan
25. The mannose receptor mediates uptake of pathogenic and non-pathogenic mycobacteria and bypasses bactericidal response in human macrophages
26. Ciq receptors: Upregulating specific functions of phagocytic cells
27. Mannose binding protein B allele confers protection against tuberculous meningitis
28. Sequential production of Th1 and Th2 cytokines in response to live bacillus Calmette-Guerin
29. Role of tumour necrosis factor-α in mycobacterium-induced granuloma formation in tumour necrosis factor-α-deficient mice
30. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon-γ and tumour necrosis factor-α
31. T-cell cytokines may control the balance of functionally distinct macrophage populations
32. IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses
33. Regulation of interleukin-12 production in human cells stimulated with Mycobacterium bovis BCG
34. Expression of the IL-12 receptor beta 1 and beta 2 subunits in human tuberculosis
35. Severe mycobacterial and Salmonella infection sin interleukin-12 receptor-deficient patients
36. Regulation of interleukin-12 by interleukin-10, transforming growth factor-beta, tumour necrosis factor-alpha and interferon gamma in human monocytes infected with Mycobacterium tuberculosis H37Ra
37. Tumour necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy
38. Evidence that genetic susceptibility to Mycobacterium tuberculosis in a Brazilian population is under oligogenic control: Linkage study of the candidate genes NRAMP1 and TNFA
39. Selective induction of transforming growth factor beta in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis
40. Mycobacterial cell wall components induce the production of TNF-α, IL-1 and IL-6 by bovine monocytes and the murine macrophage cell line RAW 264.7
41. Variation in protection by BCG: Implications of and for heterologous immunity